| Shawn Quinn, DO | |
|
1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 | |
| (610) 402-8111 | |
| Not Available |
| Full Name | Shawn Quinn |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 1200 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144436973 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | OS014506 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
A new physical effect has been demonstrated at the University of Bath after 40 years of pursuit by physicists around the world, which could lead to advancements in chemical manufacturing efficiency, miniaturization and quality control in personalized pharmaceuticals.
The Affordable Care Act helped many become insured, yet 31 million people are "underinsured" with high deductible plans and face out-of-pocket medical costs that can cause serious financial stress.
Worldwide, Indo-Asian people are among the populations at greatest risk for heart disease. Also, associations between body mass index (BMI) and chronic disease may differ between Indo-Asian and Western populations.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
› Verified 2 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
A new physical effect has been demonstrated at the University of Bath after 40 years of pursuit by physicists around the world, which could lead to advancements in chemical manufacturing efficiency, miniaturization and quality control in personalized pharmaceuticals.
The Affordable Care Act helped many become insured, yet 31 million people are "underinsured" with high deductible plans and face out-of-pocket medical costs that can cause serious financial stress.
Worldwide, Indo-Asian people are among the populations at greatest risk for heart disease. Also, associations between body mass index (BMI) and chronic disease may differ between Indo-Asian and Western populations.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shawn Quinn, DO Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Shawn Quinn, DO 1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 Ph: (610) 402-8111 |
News Archive
A new physical effect has been demonstrated at the University of Bath after 40 years of pursuit by physicists around the world, which could lead to advancements in chemical manufacturing efficiency, miniaturization and quality control in personalized pharmaceuticals.
The Affordable Care Act helped many become insured, yet 31 million people are "underinsured" with high deductible plans and face out-of-pocket medical costs that can cause serious financial stress.
Worldwide, Indo-Asian people are among the populations at greatest risk for heart disease. Also, associations between body mass index (BMI) and chronic disease may differ between Indo-Asian and Western populations.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
› Verified 2 days ago
Alex Rosenau, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8111 | |
John Mccarthy, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8111 | |
David Eric Wiand, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1736 W Hamilton St, Allentown, PA 18104 Phone: 610-628-8384 | |
Dr. Susan K Yaeger, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-9750 Fax: 610-402-9763 | |
Dr. Jarod Berggren, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
Tyler Frank Willing, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8111 | |
Sean Mcglinn, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1736 W Hamilton St, Allentown, PA 18104 Phone: 610-770-8379 |